mRNA |
cediranib |
CTRPv2 |
pan-cancer |
AAC |
0.0053 |
0.9 |
mRNA |
BRD9876 |
CTRPv2 |
pan-cancer |
AAC |
-0.0037 |
0.9 |
mRNA |
ZSTK474 |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |
mRNA |
importazole |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
mRNA |
tanespimycin:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
mRNA |
CH5424802 |
GDSC1000 |
pan-cancer |
AAC |
-0.0025 |
0.9 |
mRNA |
paclitaxel |
GDSC1000 |
pan-cancer |
AAC |
-0.0038 |
0.9 |
mRNA |
SB-525334 |
CTRPv2 |
pan-cancer |
AAC |
-0.0028 |
0.9 |
mRNA |
doxorubicin:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0023 |
0.9 |
mRNA |
AA-COCF3 |
CTRPv2 |
pan-cancer |
AAC |
0.0025 |
0.9 |